Intelligence · Clinical Pipeline
First People's Hospital Pipeline
All ClinicalTrials.gov programs at First People's Hospital — phase, modality, and trial IDs.
- Programs
- 1,136
Quick answer
First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Buspirone
The First People's Hospital of Lianyungang
Anxiety Disorders
1 trial -
CAR-CD19 T cell
The First People's Hospital of Lianyungang
B Cell Lymphoma
1 trial -
CCTA, CT-MPI, DSA, FFR
The First People's Hospital of Lianyungang
Coronary Microvascular Disease
1 trial -
CD19 CAR-T cells infusion
The First People's Hospital of Lianyungang
Non Hodgkin Lymphoma
1 trial -
CMOP+Chidamide
The First People's Hospital of Lianyungang
Newly Diagnosed Peripheral T-cell Lymphoma
1 trial -
CT-FFR assessment
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
CT0590 CAR T Cells
The First People's Hospital of Lianyungang
Relapsed and/or Refractory Multiple Myeloma
1 trial -
CT0594CP
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial -
Canagliflozin
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus With Complication
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Cholangiocarcinoma
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Cefotiam
The First People's Hospital of Lianyungang
Gastric Varices
1 trial -
Celecoxib
The First People's Hospital of Lianyungang
Low Back Pain
1 trial -
Chemotherapy drug
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma, Adult
1 trial -
Chi-GVM
The First People's Hospital of Lianyungang
Relapsed/Refractory Peripheral T-cell Lymphoma
1 trial -
Chinese herbal medicine
The First People's Hospital of Lianyungang
Acute on Chronic Liver Failure
1 trial -
Combination Product: Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Combination of chemotherapy and immunotherapy
The First People's Hospital of Lianyungang
Non Small Cell Lung Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Contrast-enhanced ultrasound-guided core biopsy
The First People's Hospital of Lianyungang
Pancreatic Disease
1 trial -
Control lidocaine cream
The First People's Hospital of Lianyungang
Atopic Dermatitis
1 trial -
Controlled low central venous pressure (CLCVP) technology
The First People's Hospital of Lianyungang
Acute Kidney Injury
1 trial -
Conventional second-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Cyclosporin A
The First People's Hospital of Lianyungang
Acute Leukemia
1 trial -
DPP4
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial -
Daphne Extract Capsules
The First People's Hospital of Lianyungang
Epithelial Ovarian Cancer
1 trial -
Daratumumab
The First People's Hospital of Lianyungang
Antibody-mediated Rejection
1 trial -
Dasatinib
The First People's Hospital of Lianyungang
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1 trial -
Dentoblis
The First People's Hospital of Lianyungang
Gingivitis; Chronic
2 trials -
Deucravacitinib
The First People's Hospital of Lianyungang
Palmoplantar Pustulosis
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Cataract
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Anxiety
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Failure
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Benign Neoplasm of Vocal Fold - Glottis
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Old Age
1 trial -
Dexmedetomidine Injection
The First People's Hospital of Lianyungang
Coronary Disease
1 trial -
Dexmedetomidine ropivacaine
The First People's Hospital of Lianyungang
Pharmacological Action
1 trial -
Dexmedetomidine-Esketamine Combination
The First People's Hospital of Lianyungang
Aged
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Liver Cancer
1 trial -
Dextrometropine and 0.9% sodium chloride solution
The First People's Hospital of Lianyungang
Cataract
1 trial -
Diagnostic Test: conventional imaging (CT, MRI or 18F-FDG PET/CT), DLL3-targeted PET/CT
The First People's Hospital of Lianyungang
DLL3-expressing Tumors
1 trial -
Diagnostic Test: standard-of-care imaging (68Ga-PSMA PET/CT), 68Ga-XACP3 PET/CT
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Disitamab Vedotin combined with Zimberelizumab
The First People's Hospital of Lianyungang
Biliary Carcinoma
1 trial -
Docetaxel
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Docetaxel
The First People's Hospital of Lianyungang
Esophageal Neoplasms
1 trial
Frequently asked questions
How many pipeline programs does First People's Hospital have?
1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs